NRD
SWAV

Nebula Research & Development’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Nebula Research & Development’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,067
Closed -$394K – 1041
2023
Q4 		$394K Buy
+2,067
New +$391K 0.12% 327

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nebula Research & Development's SWAV Position: Q1 2024 in Review

Nebula Research & Development sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 2,067 shares — an estimated $394K sold.

Nebula Research & Development first reported a position in SWAV in Q4 2023 and held it in 1 quarter. The position peaked at $394K in Q4 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Nebula Research & Development reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nebula Research & Development sold 2,067 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $394K.
  • Nebula Research & Development first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Nebula Research & Development's Shockwave Medical, Inc. Common Stock position peaked at $394K in Q4 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Nebula Research & Development's 13F filing for Q1 2024, filed 15 May 2024.